COntinuous Patient Education project (COPE)
A guide to COPE

Monitoring of Pharmaceutical Supply in countries of Eastern Europe, Central Asia and Caucasus
Through a training and workshop regional groups will be exposed to international and regional expertise in relevant issues and will plan research and reporting. Research will be conducted based on a standardized set of parameters and unified approach to information collection. Research will be carried out in 5-7 countries (of the region – Russia, Kazakhstan, Kyrgyzstan, Tadzikistan, Ukraine, Moldova, Estonia). The final reports will serve to call attention to specific areas for improvement and making constructive suggestions. They will be presented at the national level and in major regional and international events in 2008 – EECAAC, UNGASS, WAC etc.

Benefits of the universal access of HIV prevention, treatment and care for the vulnerable in Europe and Central Asia
The proposed project aims to facilitate advocacy for reaching the universal access to HIV prevention, treatment and care for vulnerable groups in the European continent. It will prepare an advocacy instrument listing epidemiological, public health, economic and human rights arguments for the universal access and effectively serving HIV affected groups in the region. The advocacy instrument will appear as an extensive review of who is the vulnerable, public arguments and economic arguments for the full coverage, as well as focus on three groups -- migrants, MSM, injecting drug users. It will be printed and will be followed by a series of ‘satellites’ (summary document in English and Russian, presentations at national and international events, articles at least in three journals, press release). The project will facilitate presentation of the paper at European, other regional, as well as international events, special national round tables in 5 countries for policy makers and advocates, media (European, national) and dissemination of hard copies of the papers. The project will last for one year. It will be managed by the group of EATG members with external advisory board and a number of experts will be employed for its implementation.

Vaccines Meeting
In 2001, EATG’s ECAB organised a meeting on AIDS vaccines R&D issues. Stakeholders attending the meeting included AVAC, IAVI, the EU, amongst other organisations. The basics of immunology and vaccine research and development were explained to some 30 aids activist from all over Europe. The meeting also highlighted the challenges and opportunities in the vaccine field at that time. Given the constantly changing field of AIDS vaccine R&D, it is the time to have a follow-up meeting on vaccines to refresh, update and build upon the issues brought up at that first event. In this occasion, the meeting is conceived as a ‘thematic ECAB’ meeting as it is intended to have a vaccines R&D section as well as a section on AIDS vaccines advocacy and networking from a civil society perspective.

Hot Issues in HIV/HCV Co-infection in Southern European Countries
The Spanish community of HIV treatment activists has had co-infection issues as a top agenda priority and has developed different programs and strategies, with different degrees of impact or success. Activists from other countries in the region have expressed their will to learn more from the Spanish experience, as well from others in the region, while presenting their own work for discussion, debate, lessons learnt setting and possible common strategies for the future.

HIV treatment for people who use drugs in new EU member states, Eastern Europe and Central Asia
A two-day seminar on HIV treatment for people who use drugs, aiming at building capacity by increasing knowledge on the issue of NGOs, activists and care providers in the region countries

Clinical Trials Training - St Petersburg, Russian Federation
Second of two community training programmes on clinical trials

The right to HIV/AIDS prevention, treatment, care and support for migrants and ethnic minorities in Europe: The community perspective.
European conference in Lisbon, Portugal

Research agenda and access to experimental hepatitis-C drugs for people co-infected with HIV
Liver failure has become a major cause of death among people living with HIV in Western countries.

The silent epidemic – treatment issues in HIV/AIDS in the Central East European region
While the HIV/AIDS epidemic has become “established” in the western parts of Europe, we can register a new wave of infections in the Eastern and Central European regions.

1 2 >>